Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | AKR1B10 | O60218 | 6/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | F13A1 | P00488 | 1/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.45 |
| ▸ | TGM1 | P22735 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18355349 | 0.95 | HCAR2 (0.49) | HCAR2LMNAAKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL18353129 | 0.92 | HCAR2 (0.56) | HCAR2LMNAAKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL18355457 | 0.87 | HCAR2 (0.51) | HCAR2LMNAAKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL25973768 | 0.85 | ALDH1A1 (0.47) | LMNAALDH1A1KDM4EF13A1TGM2 | |
| SCHEMBL1896919 | 0.83 | ALDH1A1 (0.49) | ALDH1A1F13A1TGM2TGM1CHRNB2 | |
| SCHEMBL7367495 | 0.82 | ALDH1A1 (0.58) | HCAR2LMNAALDH1A1F13A1TGM2 | |
| SCHEMBL27353515 | 0.82 | TGM2 (0.51) | HCAR2LMNAAKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL18352518 | 0.82 | ALDH1A1 (0.46) | HCAR2LMNAALDH1A1KDM4ETDP1 | |
| SCHEMBL20794169 | 0.81 | ALDH1A1 (0.52) | LMNAALDH1A1KDM4EF13A1TGM2 | |
| SCHEMBL1897393 | 0.81 | CCR6 (0.51) | HCAR2LMNAALDH1A1F13A1TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170001952-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2017-01-05 | — | — | US | disclosed |
| US-20170001952-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170001952-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | FH, FPGS, APC | HCAR2 290/4885LMNA 4358/4885AKR1B10 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.